Neoadjuvant pamiparib in patients with newly diagnosed advanced ovarian cancer: A single-arm, prospective phase II trial. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...
They also used an Affymetrix gene-expression array to profile the transcriptome of six different tissues. Reymond described significantly greater variation of gene expression for genes located in a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Universal Diagnostics (Universal DX), a bioinformatics and multi-omics company on a mission to transform cancer into a curable disease, today announced the results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results